Eddie Vedder’s ‘Matter of Time’ Documentary Debuts on Netflix with Premiere Date
Eddie Vedder, the iconic lead singer of Pearl Jam, continues his commitment to fighting Epidermolysis Bullosa (EB). His new documentary, titled “Matter of Time,” focuses on this rare genetic skin condition and the efforts to find a cure. Netflix will premiere the film on February 9.
Fundraising Efforts for Epidermolysis Bullosa
In 2010, Eddie Vedder and his wife, Jill Vedder, established the EB Research Partnership (EBRP). This nonprofit organization aims to fund research targeting treatment and a cure for EB, which has profoundly impacted the lives of many, including the child of Jill’s childhood friend.
Documentary Highlights
“Matter of Time” features Vedder hosting a fundraising concert in Seattle, which seeks to raise awareness and funds for EB research. The documentary intertwines footage of this concert with personal narratives from families, researchers, and young patients living with the condition.
Performance and Community Support
- In October 2023, Vedder held two sold-out solo concerts at Seattle’s Benaroya Hall.
- All proceeds from these performances were directed to support vital EB research.
Acknowledging the Team Behind the Film
The documentary is directed by Matt Finlin, known for “The Movie Man,” and produced by Door Knocker Media, in collaboration with EBRP and the Vitalogy Foundation. It has already been recognized at festivals, including:
- Tribeca Film Festival: Premiered last year
- Nashville Film Festival: Won Best Feature Music Documentary
- San Diego International Film Festival: Awarded Best Picture
Messages from the Filmmakers
Eddie Vedder expressed that the film captures the essence of the EB community, highlighting the inspiring stories of individuals dedicated to the cause. “This isn’t just a concert film. It’s a portrait of a community working together toward a common dream,” he stated.
Jill Vedder emphasized the honor she feels serving the EB community, stating, “Matter of Time shows the power of a community united for a singular purpose.” Michael Hund, CEO of EBRP, called the documentary a movement. He noted it demonstrates that success in developing treatments for rare diseases is achievable through collaboration among patients, families, and the scientific community.
As anticipation builds for “Matter of Time,” viewers are encouraged to engage with the powerful narratives presented in the film. The documentary portrays not only the struggles associated with EB but also the collective determination to create change.
